Literature DB >> 12354713

Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): the INOP Test Study Group.

David T Balzer1, Henry W Kort, Ronald W Day, Howard M Corneli, John P Kovalchin, Bryan C Cannon, Stephen F Kaine, D Dunbar Ivy, Steven A Webber, Abraham Rothman, Robert D Ross, Sanjeev Aggarwal, Masato Takahashi, J Deane Waldman.   

Abstract

BACKGROUND: This study was performed to determine whether a preoperative hemodynamic evaluation with oxygen and inhaled nitric oxide identifies patients with pulmonary hypertension who are appropriate candidates for corrective cardiac surgery or transplantation more accurately than an evaluation with oxygen alone. METHODS AND
RESULTS: At 10 institutions, 124 patients with heart disease and severe pulmonary hypertension underwent cardiac catheterization to determine operability. The ratio of pulmonary and systemic vascular resistance (Rp:Rs) was determined at baseline while breathing approximately 21% to 30% oxygen, and in approximately 100% oxygen and approximately 100% oxygen with 10 to 80 parts per million nitric oxide to evaluate pulmonary vascular reactivity. Surgery was performed in 74 patients. Twelve patients died or developed right heart failure secondary to pulmonary hypertension following surgery. Rp:Rs<0.33 and a 20% decrease in Rp:Rs from baseline were chosen as 2 criteria for operability to determine, in retrospect, the efficacy of preoperative testing in patient selection. In comparison to an evaluation with oxygen alone, sensitivity (64% versus 97%) and accuracy (68% versus 90%) were increased by an evaluation with oxygen and nitric oxide when Rp:Rs<0.33 was used as the criterion for operability. Specificity was only 8% when a 20% decrease in Rp:Rs from baseline was used as the criterion for operability.
CONCLUSION: By using a combination of oxygen and inhaled nitric oxide, a greater number of appropriate candidates for corrective cardiac surgery or transplantation can be identified during preoperative testing when a specific value of Rp:Rs is used as a criterion for operability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354713

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  37 in total

Review 1.  Advances in pediatric pulmonary arterial hypertension.

Authors:  Dunbar Ivy
Journal:  Curr Opin Cardiol       Date:  2012-03       Impact factor: 2.161

2.  EXPRESS: Parameters associated with outcome in pediatric patients with congenital heart disease and pulmonary hypertension subjected to combined vasodilator and surgical treatments.

Authors:  Ana Maria Thomaz; Luiz Junya Kajita; Vera D Aiello; Leína Zorzanelli; Filomena Rbg Galas; Cleide G Machado; Miguel Barbero-Marcial; Marcelo B Jatene; Marlene Rabinovitch; Antonio Augusto Lopes
Journal:  Pulm Circ       Date:  2019-02-26       Impact factor: 3.017

3.  Hyperoxia Reduces Oxygen Consumption in Children with Pulmonary Hypertension.

Authors:  Long Guo; Prashant Bobhate; Shine Kumar; Karunakar Vadlamudi; Tarek Kaddoura; Mohamed Elgendi; Paula Holinski; James Y Coe; Jennifer Rutledge; Ian Adatia
Journal:  Pediatr Cardiol       Date:  2017-03-18       Impact factor: 1.655

4.  Our paper 20 years later: Inhaled nitric oxide for the acute respiratory distress syndrome--discovery, current understanding, and focussed targets of future applications.

Authors:  R Rossaint; K Lewandowski; W M Zapol
Journal:  Intensive Care Med       Date:  2014-09-09       Impact factor: 17.440

5.  Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects.

Authors:  Qiangqiang Li; Konstantinos Dimopoulos; Chen Zhang; Yan Zhu; Qian Liu; Hong Gu
Journal:  Pediatr Cardiol       Date:  2018-02-09       Impact factor: 1.655

Review 6.  Inhaled nitric oxide and related therapies.

Authors:  Frederick E Barr; Duncan Macrae
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

Review 7.  Therapeutic approaches using nitric oxide in infants and children.

Authors:  Robin H Steinhorn
Journal:  Free Radic Biol Med       Date:  2011-01-13       Impact factor: 7.376

8.  Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics.

Authors:  Stephanie L Siehr; D Dunbar Ivy; Kathleen Miller-Reed; Michelle Ogawa; David N Rosenthal; Jeffrey A Feinstein
Journal:  J Heart Lung Transplant       Date:  2013-02-28       Impact factor: 10.247

9.  Mechanics and Function of the Pulmonary Vasculature: Implications for Pulmonary Vascular Disease and Right Ventricular Function.

Authors:  Steven Lammers; Devon Scott; Kendall Hunter; Wei Tan; Robin Shandas; Kurt R Stenmark
Journal:  Compr Physiol       Date:  2012-01-01       Impact factor: 9.090

Review 10.  Pulmonary Hypertension.

Authors:  Peter Oishi; Jeffrey R Fineman
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.